Podcast Medicom Medical Publishers

ACC.20/WCC virtual highlights - part 3 of 3

April 01, 2020
Podcast Medicom Medical Publishers
ACC.20/WCC virtual highlights - part 3 of 3
Chapters
0:17
Kim et al - TICO trial
2:30
Dangas et al - TWILIGHT-COMPLEX substudy
4:59
Lim et al - EXPAND trial
7:50
Ho et al - MAVERICK-HCM trial
11:00
Ho et al - MAVERICK-HCM trial (repeat)
14:10
Raal et al
17:13
Bhatt et al - REDUCE-IT EPA analysis
Podcast Medicom Medical Publishers
ACC.20/WCC virtual highlights - part 3 of 3
Apr 01, 2020

Order of abstracts:

  1. Kim et al - TICO trial - Fewer adverse events with ticagrelor monotherapy after 3 months DAPT 
  2. Dangas et al - TWILIGHT-COMPLEX substudy - Significant less bleeding with ticagrelor monotherapy after complex PCI 
  3. Lim et al - EXPAND trial - MitraClip safe and effective in real-world setting
  4. Ho et al - MAVERICK-HCM trial - Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
  5. Raal et al - Evinacumab significantly reduces LDL-C in homozygous FH patients 
  6. Bhatt et al - REDUCE-IT EPA analysis - Higher serum levels of eicosapentaenoic acid correlate with reduced CV events
Show Notes Chapter Markers

Order of abstracts:

  1. Kim et al - TICO trial - Fewer adverse events with ticagrelor monotherapy after 3 months DAPT 
  2. Dangas et al - TWILIGHT-COMPLEX substudy - Significant less bleeding with ticagrelor monotherapy after complex PCI 
  3. Lim et al - EXPAND trial - MitraClip safe and effective in real-world setting
  4. Ho et al - MAVERICK-HCM trial - Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
  5. Raal et al - Evinacumab significantly reduces LDL-C in homozygous FH patients 
  6. Bhatt et al - REDUCE-IT EPA analysis - Higher serum levels of eicosapentaenoic acid correlate with reduced CV events
Kim et al - TICO trial
Dangas et al - TWILIGHT-COMPLEX substudy
Lim et al - EXPAND trial
Ho et al - MAVERICK-HCM trial
Ho et al - MAVERICK-HCM trial (repeat)
Raal et al
Bhatt et al - REDUCE-IT EPA analysis